Target intelligence / Profile preview

Dermal connective tissue

Molecular classification
Other
01

Overview

Host dermal connective tissue, commonly known as the dermis, is the thick layer of skin located between the epidermis and the subcutaneous fat. It is primarily composed of an extracellular matrix (ECM) containing collagen and elastic fibers, which provide the skin with essential tensile strength and elasticity (StatPearls, 2023). The dermis serves as a home for various specialized structures, including blood vessels, lymphatics, nerves, hair follicles, and sweat glands, and it plays a vital role in thermoregulation and sensory perception (NIH, 2022). Within this tissue, fibroblasts are the predominant cell type responsible for synthesizing the ECM, while resident immune cells provide a first line of defense against pathogens. In clinical practice, the dermal connective tissue is the site of pathology for numerous conditions such as systemic sclerosis, keloids, and chronic wounds (PubMed, 2021). While the tissue itself is an anatomical structure rather than a single molecular target, its individual components—such as specific collagen types or enzymes like matrix metalloproteinases—are frequently targeted by pharmacological agents to treat skin aging, inflammation, and fibrotic disorders.

Other names
DermisCoriumCutis veraDermal layer
02

Mechanism of action

Drugs interacting with this tissue typically function by enzymatically degrading extracellular matrix components, providing structural volume through supplementation, stimulating fibroblast activity to increase collagen synthesis, or suppressing local inflammatory cytokine production within the dermal environment (StatPearls, 2023; PubMed, 2021).

03

Biological functions

Immune responseOther
04

Disease associations

InflammationOther
05

Safety considerations

Dermal atrophyDelayed wound healingTissue fibrosisHypersensitivity reactionsTelangiectasia
06

Interacting drugs

Collagenase clostridium histolyticum

4 more in the full profile.

07

Biomarkers

Collagen type ICollagen type IIIElastinFibroblast activation protein (FAP)Matrix metalloproteinase-1 (MMP-1)

Beyond the preview

Go deeper on Dermal connective tissue.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dermal connective tissue.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call